Financial Data and Key Metrics Changes - For the full year 2025, the company reported revenues of $90.9 million, an increase from $86.9 million in 2024, driven primarily by the drone segment [27] - Fourth quarter revenue was $48.3 million, up from $39.7 million in the same quarter of 2024, reflecting strong execution particularly in the drone and training segments [25] - EBITDA for the full year was $24.7 million compared to -$13.1 million in 2024, indicating a significant improvement in operational performance [28] Business Line Data and Key Metrics Changes - Drones represented approximately 87% of total revenue in 2025, continuing to be the primary growth driver for the company [9] - The training division secured a $1.9 million contract to support U.S. Navy training programs, enhancing naval readiness [16] - The avionics segment advanced the development of the NexNav MAX 2 and secured multi-year OEM purchase orders, contributing to the overall growth strategy [17] Market Data and Key Metrics Changes - The company has a strong order pipeline with approximately $150 million in drone segment backlog as of March 31, 2026, providing visibility into future revenue [29] - Demand for combat-proven autonomous ISR systems remains strong across NATO-aligned nations and allied defense customers [10] - The macro environment is supportive with sustained increases in defense spending across NATO and allied nations, driven by modernization requirements [18] Company Strategy and Development Direction - The company is focusing on medium-lift, multi-role unmanned platforms that support logistics, ISR, and other mission-critical applications [6] - Strategic joint ventures with Nord-Drone Group and Bullet are expected to enhance the company's capabilities and market reach [13][14] - The company is shifting away from passenger eVTOL concepts to concentrate on multi-role, medium-lift drones, aligning with immediate demand and procurement cycles [22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to capitalize on increasing defense spending and evolving threat profiles [18] - The outlook for full year 2026 anticipates revenue growth of 15%-25%, not including potential contributions from joint ventures [30] - The company is committed to scaling its business through strategic investments in R&D, manufacturing, and partnerships [31] Other Important Information - The company successfully went public in 2025, strengthening its balance sheet and expanding its manufacturing footprint [8] - Cash on the balance sheet as of December 31, 2025, was $74.4 million, providing substantial resources for growth investments [28] Q&A Session Summary Question: Strategy change on air mobility and R&D investments - Management confirmed that capital expenditure will drop off as the focus shifts to multi-role, medium-lift cargo vehicles, which are expected to add meaningful revenues post-2027 [35] Question: Customer demand mix between U.S. and international - The backlog is approximately $150 million, with strong visibility on a significant portion converting to revenue over the next 12 months, primarily driven by international demand [37] Question: Mix of definitive and undefinitive orders in backlog - Management reassured that the backlog is based on a thorough analysis of customer orders, with confidence in the $150 million firm backlog for the next 12 months [44] Question: U.S. sales outlook and potential upside - The Phoenix facility is operational, with plans to produce up to 100 units per month, and management expects to see activity in the U.S. market in the near future [51] Question: Financial impact of joint ventures - Joint ventures are expected to be accretive to the company's financials, with contributions from various conflicts around the globe rolling into the joint venture [63]

Financial Data and Key Metrics Changes - Revenue for fiscal year 2025 was $229 million, up 72% year-over-year [28] - Operating loss for fiscal year 2025 was $150 million, compared to an operating loss of $28 million in 2024 [28][29] - Net loss for 2025 was $209 million, or $0.38 loss per share, compared to a net loss of $7 million, or $0.02 loss per share in 2024 [29] - Adjusted EBITDA for 2025 was $29 million, down from $31 million in 2024 [30] Business Line Data and Key Metrics Changes - The company has shifted focus entirely to North American HPC infrastructure development, moving away from Bitcoin mining [5][6] - The transition includes a significant capital raise of $588 million, which was fully institutional and oversubscribed [11][31] - The company is now positioned as Keel Infrastructure, emphasizing its role in supporting AI and HPC infrastructure [6][10] Market Data and Key Metrics Changes - The company has secured over 2 GW in its pipeline, making it a regional leader in high-demand markets [8][14] - The demand for power and land for AI infrastructure is increasing, with significant barriers to entry in the markets where the company operates [15][25] - The company is experiencing a surge in customer interest, particularly after securing zoning for its Panther Creek site [15] Company Strategy and Development Direction - The company aims to provide critical infrastructure for AI platforms, focusing on colocation facilities rather than competing with hyperscalers [7][10] - The strategy includes a disciplined exit from Bitcoin mining, with plans to reinvest capital into HPC and AI infrastructure [13][24] - The company is focused on executing its three-year transformation plan, with 2026 being a year of execution and 2027 anticipated for revenue generation [11][13] Management's Comments on Operating Environment and Future Outlook - Management believes that the demand for power will remain a structural bottleneck for AI infrastructure deployment [16] - The company is confident in its ability to secure leases and generate revenue as it progresses through permitting and site development [12][20] - The management emphasizes the importance of securing favorable lease terms to maximize shareholder value [40][41] Other Important Information - The company will officially rebrand as Keel Infrastructure and begin trading under the new ticker on Nasdaq and TSX [8][12] - The company has a strong liquidity position of $520 million, providing flexibility for future developments [31][32] Q&A Session Summary Question: What were the major drivers for the decision to focus on colocation instead of GPU rental at Moses Lake? - The decision was based on increasing customer conversations indicating that remaining a pure play infrastructure developer would maximize shareholder value [39] Question: Can you update on the lease execution strategy and potential timing? - The strategy remains consistent, focusing on securing the best lease terms to drive long-term value [40][41] Question: What permits are still pending at the various sites? - Permitting is a complex process with progress expected in the coming months, aiming for full permitted status across sites by mid to late summer [46] Question: What is the timeline for data center construction and revenue generation? - The company expects to start generating revenue from its sites in 2027, following the completion of permitting and lease execution [82] Question: How is the company managing its Bitcoin mining operations during the transition? - The company is scaling back its mining operations while maximizing free cash flow before transitioning fully to HPC and AI infrastructure [76][84]

J.Jill (NYSE:JILL) Q4 2026 Earnings call March 31, 2026 08:00 AM ET Company ParticipantsAnna Linscott - Equity Research AssociateCorey Tarlowe - SVP of Equity ResearchDana Telsey - CEO and Chief Research OfficerEthan Saghi - VP of Equity ResearchJonna Kim - DirectorMark Webb - EVP, CFO, and COOMary Ellen Coyne - CEO and PresidentOperatorThank you for standing by. My name is Jael, and I'll be your conference operator today. At this time, I would like to welcome everyone to the J.Jill's fourth quarter 2025 ea ...

T1 Energy (NYSE:FREY) Q4 2025 Earnings call March 31, 2026 08:00 AM ET Company ParticipantsAndy Munro - Chief Legal and Policy OfficerDan Barcelo - CEO and Chairman of the BoardEvan Calio - CFOGregory Lewis - Managing DirectorJeffrey Spittel - EVP of Investor Relations and Corporate DevelopmentOtto Erster Bergesen - SVP of Project EngineeringConference Call ParticipantsPhilip Shen - Senior Research AnalystSean Milligan - Managing Director and Equity Research AnalystOperatorGood day, and thank you for standi ...

Financial Data and Key Metrics Changes - For the full year 2025, the company reported revenues of $90.9 million, an increase from $86.9 million in 2024, driven primarily by the drone segment [27] - Fourth quarter revenue was $48.3 million, up from $39.7 million in Q4 2024, reflecting strong execution particularly in the drone and training segments [25] - EBITDA for 2025 was $24.7 million compared to -$13.1 million in 2024, indicating a significant improvement in operational performance [28] Business Line Data and Key Metrics Changes - Drones accounted for approximately 87% of total revenue in 2025, highlighting their role as the primary growth driver for the company [9] - The training division secured a $1.9 million contract to support U.S. Navy training programs, enhancing naval readiness [16] - The avionics segment advanced the development of the NexNav MAX 2 and secured multi-year OEM purchase orders, contributing to overall growth [17] Market Data and Key Metrics Changes - The company has a strong order pipeline with approximately $150 million in drone segment backlog as of March 31, 2026, providing visibility into future revenue [29] - Demand for combat-proven autonomous ISR systems remains strong across NATO-aligned nations and allied defense customers [10] - The macro environment is supportive with sustained increases in defense spending across NATO and allied nations driven by modernization requirements [18] Company Strategy and Development Direction - The company is focusing on medium-lift, multi-role unmanned platforms that support logistics, ISR, and other mission-critical applications [6] - Strategic joint ventures with Nord Drone Group and Bullet are expected to enhance production capabilities and expand market reach [13][14] - The company is shifting away from passenger eVTOL concepts to concentrate on multi-role, medium-lift drones, aligning with immediate demand and procurement cycles [22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to capitalize on increasing defense spending and evolving threat profiles [18] - The outlook for full year 2026 revenue growth is projected at 15%-25%, not including potential contributions from joint ventures [30] - The company is committed to scaling its business while maintaining a disciplined approach to capital expenditures [20] Other Important Information - The company successfully went public in 2025, strengthening its balance sheet with $74.4 million in cash as of December 31, 2025 [28] - The modernization of the Støvring facility in Denmark is intended to increase production throughput as demand expands [12] - The company is investing in artificial intelligence and edge computing to broaden its solution portfolio [11] Q&A Session Summary Question: Strategy change on air mobility and R&D investments - Management confirmed that capital expenditures will decrease as the focus shifts from passenger eVTOL to multi-role, medium-lift cargo vehicles, which are expected to generate meaningful revenues post-2027 [35] Question: Customer demand mix between U.S. and international - The backlog is approximately $150 million, with strong visibility on a significant portion converting to revenue over the next 12 months, primarily driven by international demand [37] Question: Mix of definitive and undefinitive orders in backlog - Management reassured that the backlog is based on a thorough analysis of customer orders, with confidence in the $150 million firm backlog for the next 12 months [44] Question: U.S. sales outlook and potential upside - The Phoenix facility is operational, with plans to produce up to 100 units per month, and management expects to see increased activity in the U.S. market [51] Question: Financial impact of joint ventures - Joint ventures are expected to contribute positively to the bottom line, with potential revenue not included in the current guidance [63]

Constellation Energy Corporation Conference Call Summary Company Overview - **Company**: Constellation Energy Corporation (NasdaqGS: CEG) - **Date of Call**: March 31, 2026 - **Key Speakers**: Joe Dominguez (President and CEO), Shane Smith (CFO) Core Industry Insights - **Growth Projections**: Constellation expects a **20% compound annual growth rate (CAGR)** on base earnings through 2029, based on conservative assumptions [5][46] - **Market Position**: Constellation is positioned as the largest private sector power producer globally, generating nearly **300 million megawatt-hours annually**, with two-thirds being carbon-free [16][58] Financial Highlights - **2025 Performance**: Adjusted operating EPS for 2025 was **$9.39**, exceeding guidance for four consecutive years [39] - **2026 Guidance**: Initiating adjusted operating EPS guidance for 2026 at **$11 to $12 per share** [39][40] - **Share Repurchase**: Increased buyback authorization to **$5 billion**, reflecting confidence in business strategy [14][41] Strategic Developments - **Calpine Acquisition**: The integration of Calpine is progressing well, enhancing Constellation's scale and operational capabilities [31][52] - **Long-term Contracts**: Constellation has executed deals for over **10,000 megawatts** of its fleet, serving diverse customer types [16][17] Regulatory and Market Dynamics - **PJM Regulatory Clarity**: Ongoing discussions with FERC aim to provide clarity on regulatory frameworks affecting data centers and energy procurement [24][25] - **Data Center Development**: Constellation is adapting to regulatory changes and customer needs, focusing on clean and reliable power solutions [8][10] Customer Engagement and Solutions - **Diverse Customer Base**: Agreements span multiple sectors, including hyperscalers, commercial customers, and government entities [17][18] - **Energy Solutions**: Offering a broad suite of energy solutions, including virtual PPAs and long-term contracts, to meet sustainability goals [22][23] Operational Excellence - **Nuclear Fleet Performance**: Constellation's nuclear assets outperform industry averages, contributing to additional clean energy generation [34] - **Innovative Practices**: Transitioning to new fuels for longer refueling cycles, reducing operational costs and increasing grid availability [35] Future Outlook - **Investment Plans**: Expected to invest approximately **$3.9 billion** in growth projects during 2026 and 2027, focusing on enhancing existing fleet performance [53] - **Market Demand**: Anticipating significant demand for clean energy solutions as the grid becomes more electrified and data-driven [52][58] Key Risks and Considerations - **Regulatory Scrutiny**: Increased scrutiny on data center developments may impact future project timelines and customer agreements [6][7] - **Market Volatility**: Potential fluctuations in market conditions and inflation could affect earnings and operational strategies [20][21] Conclusion - Constellation Energy is positioned for robust growth with a strong focus on clean energy solutions, operational excellence, and strategic capital allocation, aiming to deliver significant value to shareholders through disciplined execution and innovative energy offerings [60][61]

McCormick & Company (NYSE:MKC) Q1 2026 Earnings call March 31, 2026 08:00 AM ET Company ParticipantsAndrew Lazar - Managing DirectorBrendan Foley - Chairman, President, and CEOFaten Freiha - VP of Investor RelationsFernando Fernández - CEOMarcos Gabriel - EVP and CFOMax Gumport - Director of Equity ResearchPeter Galbo - Managing Director and Head of US Consumer Staples Equity ResearchRobert Moskow - Managing DirectorConference Call ParticipantsAlexia Howard - Research AnalystScott Marks - Equity Research An ...

Financial Data and Key Metrics Changes - As of December 31, 2025, the company held approximately EUR 230.9 million in cash equivalents and short-term deposits, supported by significant financing events in 2025, including EUR 108 million from structured financing and EUR 139.4 million from a public offering [14][15] - R&D expenses for the full year were EUR 87 million, reflecting the prioritization of the pipeline, while marketing and business development expenses increased to EUR 5 million due to pre-commercial investments [15][16] - General and administrative expenses totaled EUR 47.9 million, including EUR 20.3 million in non-cash share-based compensation related to governance transitions [16] Business Line Data and Key Metrics Changes - The company has focused all resources on lanifibranor and MASH, selling global rights to odiparcil for up to $90 million in potential milestone payments and royalties [5][6] - The NATiV3 trial, a pivotal phase III clinical trial, completed enrollment in April 2025 with over 1,000 patients, exceeding original targets [12] Market Data and Key Metrics Changes - An estimated 18 million people in the U.S. live with MASH, with only about 10% diagnosed, a 25% increase from 2024 estimates [7] - Among those diagnosed with clinically actionable F2 or F3 disease, only around 40% are currently under the care of a physician, indicating a significant unmet need [7] Company Strategy and Development Direction - The company aims to advance lanifibranor towards approval for patients with MASH, with a top-line readout expected in Q4 2026 [4][17] - The leadership team has been strengthened to align with the opportunity, focusing on regulatory and commercial readiness for a potential launch [6][17] - The company plans to build awareness and improve screening for MASH, addressing the underdiagnosis and undertreatment of the condition [6] Management's Comments on Operating Environment and Future Outlook - Management believes that if the NATiV3 trial replicates the 18% fibrosis improvement seen in phase II, lanifibranor could be positioned as a leading oral therapy with significant commercial impact [7][21] - The company acknowledges the growing market interest in MASH treatments, particularly in the diabetic patient population, and sees a strong entry point for lanifibranor [21] Other Important Information - The company is preparing for potential commercialization of lanifibranor, with a focus on regulatory and commercial readiness [6][17] - The NATiV3 trial is designed to confirm findings from the phase IIb NATIVE trial, with a primary endpoint of fibrosis improvement and MASH resolution [10][11] Q&A Session Summary Question: Can you update us on the performance of the trial in terms of dropouts? - The dropout rate is below 30%, which was the threshold set for the trial, and the trial is well-powered to detect the primary endpoint [23][24] Question: How are you thinking about the performance of the 800 versus the 1200 milligram dose? - The 800 mg dose may catch up to the 1200 mg dose over time, and both doses are expected to have strong efficacy with different tolerability profiles [25][26] Question: What are you seeing in terms of overall market interest? - There is significant market growth due to increased awareness and unmet needs, particularly in the F3 diabetic patient population [21] Question: What quality control protocols are in place for analyzing biopsy samples? - The clinical development team has extensive experience, and quality control measures are in place to ensure proper biopsy collection and assessment [32] Question: What is the expected effect size for the primary endpoint in NATiV3? - The trial is powered to detect a smaller treatment effect than seen in phase II, with a focus on a composite endpoint that is less prone to placebo response [38][39] Question: How do you view the F3 diabetic population in terms of market opportunity? - Approximately 375,000 patients with F2 and F3 are currently in treatment, with a significant portion being diabetic, indicating a large market opportunity [41] Question: What are the expectations for the exploratory cohort of F4 patients? - The exploratory cohort will provide insights into safety and potential efficacy in a more advanced disease population, which will inform future trial designs [53] Question: How does background GLP-1 use impact lanifibranor's effect size? - Background GLP-1 use is expected to have minimal impact on treatment response, as patients enter the trial with active MASH regardless of other medications [87]

Summary of Repay Holdings Corporation's Acquisition Overview Conference Call Company and Industry - **Company**: Repay Holdings Corporation - **Acquisition Target**: KUBRA - **Industry**: Digital bill payment and consumer communications Core Points and Arguments - **Acquisition Announcement**: Repay has reached a definitive agreement to acquire KUBRA for a purchase price of $372 million, aiming to create a leading bill payment provider in North America [4][8] - **Market Position**: The combined entity will interact with over 40% of U.S. and Canadian households monthly and process over $130 billion in annual payment volumes [5][4] - **Financial Projections**: Combined revenue for 2025 is projected to be approximately $548 million, with Adjusted EBITDA around $178 million [5][9] - **Synergies and Growth**: The acquisition is expected to be approximately 25% accretive to free cash flow by 2028, with identified annual run rate expense synergies of about $15 million [7][10] - **Operational Integration**: The integration of KUBRA's billing and consumer communication platform with Repay's payment processing capabilities is expected to enhance service offerings across various verticals [6][10] Additional Important Content - **Financing Details**: The acquisition will be financed through cash on hand and a $500 million term loan, with net leverage expected to be around 4x at closing [8][9] - **Regulatory Approval**: The transaction is anticipated to close in the second quarter of 2026, pending regulatory approvals in the U.S. and Canada [9] - **Client Base**: KUBRA serves over 250 clients, primarily in utilities and government sectors, with a strong emphasis on long-term relationships [13][16] - **Technology Integration**: The combined companies will leverage their respective technology platforms to streamline operations and enhance client services, including AI-powered solutions and mobile applications [5][6][10] - **Market Strategy**: Repay emphasizes the importance of organic growth alongside acquisitions, maintaining a focus on technology investments and client retention [21][23] - **Future Growth Expectations**: The industry is expected to grow at a mid-single-digit rate, aligning with broader market trends [47] This summary encapsulates the key points discussed during the conference call, highlighting the strategic importance of the acquisition and its anticipated impact on Repay's market position and financial performance.

McCormick & Company (NYSE:MKC) Q1 2026 Earnings call March 31, 2026 08:00 AM ET Company ParticipantsAndrew Lazar - Managing DirectorBrendan Foley - Chairman, President, and CEOFaten Freiha - VP of Investor RelationsFernando Fernández - CEOMarcos Gabriel - EVP and CFOMax Gumport - Director of Equity ResearchPeter Galbo - Managing Director and Head of US Consumer Staples Equity ResearchRobert Moskow - Managing DirectorConference Call ParticipantsAlexia Howard - Research AnalystScott Marks - Equity Research An ...